| Microorganism |
MIC50
(μg/ml) |
MIC90
(μg/ml) |
Range
(μg/ml) |
Antimicrobial |
Reference |
| Staphylococcus aureus (SG 511) |
- |
- |
1.563 － ? |
Cefotaxime (Cephotaxime, Claforan)  |
333 |
| Staphylococcus aureus (SG 511) |
- |
- |
3.12 － ? |
N-[3,8-Bis-(2,3-diacetoxybenzoyl)-3,8-diaza-octanoyl]-amoxicillin |
980 |
| Staphylococcus aureus (SH1000) |
- |
- |
0.015 － ? |
Rifampicin (Rifampin) |
1373 |
| Staphylococcus aureus (SH1000) |
- |
- |
2 － ? |
Corallopyronin A |
1373 |
| Staphylococcus aureus (SH1000) |
- |
- |
2 － ? |
Corallopyronin A |
1373 |
| Staphylococcus aureus (SH1000) |
- |
- |
2 － ? |
Myxopyronin B |
1373 |
| Staphylococcus aureus (SJ0301 + constitutively erythromycin-resistant) |
- |
- |
0.08 － ? |
Telithromycin (HMR 3647, RU-66647, Ketek) |
58 |
| Staphylococcus aureus (SJ0301 + constitutively erythromycin-resistant) |
- |
- |
40 － ? |
Azithromycin (Zithromax, Sumamed, Zitrocin) |
58 |
| Staphylococcus aureus (SJ0301 + constitutively erythromycin-resistant) |
- |
- |
40 － ? |
Clarithromycin (Biaxin) |
58 |
| Staphylococcus aureus (Smith + 14d) |
- |
- |
0.5 － ? |
Tigecycline (GAR-936, Tigacyl) |
322 |
| Staphylococcus aureus (Smith + ATCC 19636) |
- |
- |
≤0.13 － ? |
Microbisporicin |
801 |
| Staphylococcus aureus (Smith + ATCC 19636) |
- |
- |
2 － ? |
Nisin |
801 |
| Staphylococcus aureus (Smith + ATCC 19636) |
- |
- |
4 － ? |
Mersacidin |
801 |
| Staphylococcus aureus (Smith + ATCC 19636) |
- |
- |
16 － ? |
Planosporicin |
801 |
| Staphylococcus aureus (Smith + ATCC 19636) |
- |
- |
32 － ? |
Actagardine |
801 |
| Staphylococcus aureus (Smith + methicillin-susceptible) |
- |
- |
0.063 － ? |
Erythromycin (E-mycin, Ery-tab, Benzamycin) |
397 |
| Staphylococcus aureus (Smith + methicillin-susceptible) |
- |
- |
0.063 － ? |
Minocycline (Minocycline hydrochloride, Minocin) |
397 |
| Staphylococcus aureus (Smith + methicillin-susceptible) |
- |
- |
0.125 － ? |
Levofloxacin (Levaquin, Quixin) |
397 |
| Staphylococcus aureus (Smith + methicillin-susceptible) |
- |
- |
0.5 － ? |
Azamulin |
607 |
| Staphylococcus aureus (Smith + methicillin-susceptible) |
- |
- |
1 － ? |
Vancomycin (Vancocyn, Lyphocin) |
607 |
| Staphylococcus aureus (Smith + methicillin-susceptible) |
- |
- |
1 － ? |
Vancomycin (Vancocyn, Lyphocin) |
397 |
| Staphylococcus aureus (Smith + methicillin-susceptible) |
- |
- |
2 － ? |
Ceftriaxone (Rocephin) |
397 |
| Staphylococcus aureus (Smith) |
- |
- |
0.016 － ? |
Sanfetrinem cilexetil |
317 |
| Staphylococcus aureus (Smith) |
- |
- |
0.025 － ? |
Tosufloxacin |
963 |
| Staphylococcus aureus (Smith) |
- |
- |
0.06 － ? |
Cefdinir (Omnicef, Cefdiel) |
317 |
| Staphylococcus aureus (Smith) |
- |
- |
≤0.1 － ? |
2"-amino-2"-deoxyarbekacin |
730 |
| Staphylococcus aureus (Smith) |
- |
- |
≤0.1 － ? |
Arbekacin |
730 |
| Staphylococcus aureus (Smith) |
- |
- |
0.12 － ? |
Novobiocin (Albamycin) |
736 |